Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab

Copyright © 2020 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 215(2020) vom: 01. Juni, Seite 108428
Auteur principal: Pistillo, Maria Pia (Auteur)
Autres auteurs: Carosio, Roberta, Grillo, Federica, Fontana, Vincenzo, Mastracci, Luca, Morabito, Anna, Banelli, Barbara, Tanda, Enrica, Cecchi, Federica, Dozin, Beatrice, Gualco, Marina, Salvi, Sandra, Spagnolo, Francesco, Poggi, Alessandro, Queirolo, Paola
Format: Article en ligne
Langue:English
Publié: 2020
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Best overall response CTLA-4 Immunohistochemistry Ipilimumab Melanoma TIL Antineoplastic Agents, Immunological Biomarkers plus... CTLA-4 Antigen CTLA4 protein, human